Stephen Harvey Zinner, M.D.
This page shows the publications Stephen Zinner has written about Pseudomonas Infections.
Bacterial antibiotic resistance studies using in vitro dynamic models: Population analysis vs. susceptibility testing as endpoints of mutant enrichment. Int J Antimicrob Agents. 2015 Sep; 46(3):313-8.
Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model. Antimicrob Agents Chemother. 2012 Mar; 56(3):1223-8.
Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration. J Antimicrob Chemother. 2016 Mar; 71(3):678-84.
Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection. Antimicrob Agents Chemother. 1993 Sep; 37(9):1756-63.
Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model. Am J Med. 1987 Apr 27; 82(4A):363-8.
In vitro models for the study of combination antibiotic therapy in neutropenic patients. Am J Med. 1986 Jun 30; 80(6B):156-60.
Bacterial pathogens of increasing significance in hospital-acquired infections. Rev Infect Dis. 1985 Jul-Aug; 7 Suppl 3:S371-9.
Gram-negative rod bacteremia in cancer patients. A review with emphasis on the antibody response. Eur J Cancer. 1975 Aug; 11suppl:39-47.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.